Press Releases & Announcements

  • Leukocyte Telomere Length and Disease Severity in Cystic Fibrosis

    Leukocyte Telomere Length and Disease Severity in Cystic Fibrosis

    PRESS RELEASE – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 16 on August 29, 2024, entitled, “Leukocyte telomere length and attrition in association with disease severity in cystic fibrosis patients.”


Aging: Volume 16, Issue 16

Aging Blogs

Loading RSS Feed

ABOUT AGING-US.NET

Aging-US.net features interviews and testimonials from the distinguished network of authors who continue to publish their research with Aging (Aging-US)—a twice-monthly, traditional, peer-reviewed journal with open access, covering all areas of research on aging, including age-related diseases, such as cancer.

The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.

The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)

Impact Journals, the publisher of Aging (Aging-US), meets the standards of the Wellcome Trust Publisher Requirements and was included in the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.

To learn more, please visit Aging-US.com and connect with us:
Facebook | X | LinkedIn | YouTube | Instagram | Pinterest | SoundCloud

Aging Scientific Integrity
Aging Scientific Integrity